Skip to Content

Otrexup FDA Approval History

FDA Approved: Yes (First approved October 11, 2013)
Brand name: Otrexup
Generic name: methotrexate
Dosage form: Subcutaneous Injection
Company: Antares Pharma, Inc.
Treatment for: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriasis

Otrexup (methotrexate) is a folate analog metabolic inhibitor self-administered once weekly for use in the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriasis.

Development Timeline for Otrexup

Oct 15, 2013Approval Otrexup (Methotrexate) Injection Approved By FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.